Anavex Life Sciences Corp (AVXL)

[kld2]

my bad. Same thing applies to Falconer. We can try to figure out the MOA all we want, as brilliant scientists have done with molecules that have failed in clinical trials 91% of the time. In the end, it is data, data from large trials, that tells the tale. All is entertainment, at best.